ew technique in intradiscal injectio

Not Applicable

Recruiting

Conditions: Intervertebral disc disorders with radiculopathy, lumbar region.
Intervertebral disc disorders with radiculopathy, lumbar region
M51.16

Registration Number: IRCT20180603039966N3

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 70

Inclusion Criteria

consent to participate
individuals suffer from grade I and II herniated disc
spinal canal stenosis of less than 30% as determined by clinical examinations and MRI findings
chronic back pain for more than six months
symptomatic disc herniation
radial foot pain on one or both sides
no axial pain
do not have degenerative disc disease
no history of RGE injection in the last six months
no opioid usage
no coagulation disorder
not being pregnant
no history of malignancy
no history of spinal deformities, prior spine surgeries, traumatic injuries causing vertebral fractures, or infections in the vertebrae
lumbar disc herniation in L3 and/or L4
no history of neurological impairments
no history of psychiatric problems

Exclusion Criteria

Unexpected allergy to antiseptic agents
Unexpected allergy to local anesthetics
Unexpected allergy to intravenous sedatives

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Radiation exposure. Timepoint: Is mesured during the application of intervention. Method of measurement: Dose area product (DAP) meters are utilized to evaluate patient dose by employing an ionization chamber positioned on the collimator of the X-ray tube.;Procedure duration. Timepoint: The Procedure Time(PT) is carefully measured, beginning when the first fluoroscopic image was taken and ending only when the needle tip accurately reached its intended target point within the nucleus pulposus. Method of measurement: chronometer.

Secondary Outcome Measures